Table 1.
No of cases | Axillary lymphnode metastasis | P value | ||
---|---|---|---|---|
Positive | Negative | |||
Patient’s Age | NS | |||
<50 years | 51 (53.68%) | 27 | 24 | |
50–70 years | 39 (41.05%) | 19 | 20 | |
>70 years | 06 (6.31%) | 01 | 05 | |
Tumor Size | NS | |||
T1a | 04 (4.21%) | 01 | 03 | |
T1b | 07 (7.36%) | 03 | 04 | |
T1c | 15 (15.78%) | 05 | 10 | |
T2 | 46 (48.42%) | 24 | 22 | |
T3 | 25 (26.15%) | 14 | 09 | |
Histological Type | P < 0.046 | |||
DCIS | 04 (4.21%) | 00 | 04 | |
Infiltrating duct carcinoma | 68 (71.57%) | 36 | 32 | |
Infiltrating lobular carcinoma | 14 (14.73%) | 07 | 07 | |
IDC & ILC | 03 (3.15%) | 02 | 01 | |
Mucinous carcinoma | 02 (2.10%) | 00 | 02 | |
Medullary carcinoma | 02 (2.10%) | 01 | 01 | |
Tubular carcinoma | 01 (1.05%) | 00 | 01 | |
Metaplastic carcinoma | 01 (1.05%) | 01 | 00 | |
Histological Grade | P < 0.001 | |||
I | 21 (22.10%) | 05 | 16 | |
II | 49 (51.57%) | 24 | 25 | |
III | 25 (26.31%) | 14 | 09 | |
Hormonal Status | P < 0.002 | |||
ER + & PR + | 37(38.94%) | 27 | 10 | |
ER + & PR − | 21(22.10%) | 10 | 11 | |
ER-& PR + | 08(8.42%) | 02 | 06 | |
ER-& PR − | 29(30.52%) | 08 | 21 |